eyeforpharma Barcelona 2019
Exclusive live coverage from eyeforpharma Barcelona 2019, brought to you by pharmaphorum and Syneos Health.
These exclusive highlights from the eyeforpharma Barcelona 2019 conference, which takes place from Tuesday 12 to Thursday 14 March, will cover sessions on pharma market access, digital health, customer experience and behavioural change.
Other key topics in 2019 for the European eyeforpharma event include:
- New pharmaceutical commercial models
- Harnessing digital for more effective customer interaction
- Building long-lasting, meaningful patient services
- Smarter use of real-world evidence (RWE)
- New pharmaceutical innovations
- Value-driven market access
Day One live coverage, from March 12th, can be viewed by clicking on the image below:
Highlights include:
- Brent Saunders, CEO of Allergan, discusses the biggest challenges for the industry in digital transformation
- Dan Spacie, president of Selling Solutions, Europe at Syneos Health, on maximising asset value and patient outcomes by optimising resource, being agile and flexible
- A panel discussion on uniting patients, providers and payers to bring preventative care to life
Day Two live coverage, from March 13th, can be viewed by clicking on the image below:
Highlights include:
- John Zibert, chief medical officer of LEO Innovation Lab, on being disruptive from within a company
- Jennifer Turgiss, vice president of behaviour science and advanced analytics at J&J Health and Wellness Solutions, discusses scaling behavioural change to leave no patient behind
- Sir Andrew Dillon, chief executive of NICE, on accelerating patient access to new treatments
Day Three live coverage, from March 14th, can be viewed by clicking on the image below:
Highlights from day three of eyeforpharma Barcelona include:
- Keynote addresses from Kris Sterkens, company groups chairman EMEA at Janssen, and David Meek, CEO of Ipsen
- A look at how the Otsuka-Proteus collaboration has pioneered digital therapeutics as a new drug category
- The eyeforpharma Awards 2019, finalists for which include Bayer, Boehringer Ingelheim, Menarini, Novartis and Norgine
